VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market. VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs. 


Administration

Marketing & Communications

Software Engineering

Sales & Business Development

Data Science

San Francisco, CA, USA

VeriSIM Life

OCA Ventures is an early stage (Seed, Series A, and Series B) venture capital firm focused on equity investments in companies with dramatic growth potential, primarily in technology and highly-scalable services businesses. OCA invests in many industries, with a preference for technology, financial services, education and healthcare technology. Founded in 1999, the firm is investing out of its fourth fund in companies spread throughout the United States. (c)2011-2017 by Massinvestor, Inc. For contact info, please check out our about page.

OCA Ventures LLC

OCA Ventures

Are you as enthusiastic about innovation as we are? Our portfolio companies are hiring.

Careers